SOUTH SAN FRANCISCO, Calif., Sept. 1, 2011 /PRNewswire/ -- diaDexus, Inc. (OTC Bulletin Board: DDXS.OB), a diagnostics company focused on the development and commercialization of patent-protected in vitro diagnostic products addressing unmet needs in cardiovascular disease, today said that it plans to present at Baird's 2011 Health Care Conference on Thursday, September 8, 2011 at 9:30 am Eastern Time ( 6:30 am Pacific Time) at the New York Palace Hotel in New York City, NY. James Panek, Interim Chief Executive Officer, and Brian E. Ward, Interim Chief Operating Officer, will provide a corporate overview. To access the live webcast and the subsequent archived recording of the presentation, please log onto diaDexus' website at www.diadexus.com/webcast. About diaDexus, Inc. diaDexus, Inc., based in South San Francisco, California, is focused on the development and commercialization of patent-protected in vitro diagnostic products addressing unmet needs in cardiovascular disease. The company's PLAC ELISA Test for Lp-PLA2 is the only blood test cleared by the FDA to aid in assessing risk for both coronary heart disease and ischemic stroke associated with atherosclerosis. For more information, please visit the company's website at www.diaDexus.com SOURCE diaDexus, Inc.